Michael Tintiuc
Geen lopende functies
Profiel
Michael Tintiuc is a Director of Lumavita AG.
He was appointed as Senior Manager of Global Licensing for Shogoo Pharmaceuticals KK in 2006.
Prior to joining Lumavita, he worked at Dragon Pharmaceuticals, Inc. and Teijin Pharma Ltd.
Previously, Mr.Tintiuc was Head of Business Development for Wex Pharmaceuticals, Inc.
Eerdere bekende functies van Michael Tintiuc
Bedrijven | Functie | Einde |
---|---|---|
Lumavita AG
Lumavita AG Medical/Nursing ServicesHealth Services Lumavita AG is a specialty biopharmaceutical company dedicated to bring to market innovative anti-infectives for women's health. Based in Basel, Switzerland, Lumavita was recently financed by a syndicate, lead by Atlas Venture, with CHF18 million (EUR11 million). The company has one product under regulatory review in Switzerland and two further projects in clinical development. | Corporate Officer/Principal | 07-01-2014 |
WEX Pharmaceuticals, Inc.
WEX Pharmaceuticals, Inc. Medical DistributorsDistribution Services WEX Pharmaceuticals, Inc. develops, manufactures, and sells pharmaceutical products for pain management. The pain management solutions are provided through its proprietary platform technology based on TTX (Tetrodotoxin). It owns and operates its research, development and manufacturing facilities in China through its subsidiaries. The company was founded on June 3, 1987 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | - |
Teijin Pharma Ltd.
Teijin Pharma Ltd. Pharmaceuticals: MajorHealth Technology Teijin Pharma Ltd. engages in the development, production, sales, and marketing of pharmaceuticals, and medical devices and supplies. The company operates in pharmaceutical and home healthcare businesses, focusing on bone and joint diseases, respiratory diseases, and cardiovascular and metabolic diseases. The company was founded in 2002 and is headquartered in Tokyo, Japan. | Corporate Officer/Principal | - |
Dragon Pharmaceutical, Inc.
Dragon Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Dragon Pharmaceutical, Inc. produces and sells human protein therapeutics. Its products include clenbuterol, oxymetholone, dianabol and deca 300. The company was founded on August 22, 1989 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | - |
Shogoo Pharmaceuticals KK
Shogoo Pharmaceuticals KK Pharmaceuticals: MajorHealth Technology Shogoo Pharmaceuticals KK provides novel pharmaceutical products. It also licenses, develops, imports, exports, markets, and distributes pharmaceutical products. It provides medicines mainly for high unmet diseases. Shogoo Pharmaceuticals was founded in 2005 and is located in Tokyo, Japan. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 5 |
---|---|
Lumavita AG
Lumavita AG Medical/Nursing ServicesHealth Services Lumavita AG is a specialty biopharmaceutical company dedicated to bring to market innovative anti-infectives for women's health. Based in Basel, Switzerland, Lumavita was recently financed by a syndicate, lead by Atlas Venture, with CHF18 million (EUR11 million). The company has one product under regulatory review in Switzerland and two further projects in clinical development. | Health Services |
Shogoo Pharmaceuticals KK
Shogoo Pharmaceuticals KK Pharmaceuticals: MajorHealth Technology Shogoo Pharmaceuticals KK provides novel pharmaceutical products. It also licenses, develops, imports, exports, markets, and distributes pharmaceutical products. It provides medicines mainly for high unmet diseases. Shogoo Pharmaceuticals was founded in 2005 and is located in Tokyo, Japan. | Health Technology |
Dragon Pharmaceutical, Inc.
Dragon Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Dragon Pharmaceutical, Inc. produces and sells human protein therapeutics. Its products include clenbuterol, oxymetholone, dianabol and deca 300. The company was founded on August 22, 1989 and is headquartered in Vancouver, Canada. | Health Technology |
Teijin Pharma Ltd.
Teijin Pharma Ltd. Pharmaceuticals: MajorHealth Technology Teijin Pharma Ltd. engages in the development, production, sales, and marketing of pharmaceuticals, and medical devices and supplies. The company operates in pharmaceutical and home healthcare businesses, focusing on bone and joint diseases, respiratory diseases, and cardiovascular and metabolic diseases. The company was founded in 2002 and is headquartered in Tokyo, Japan. | Health Technology |
WEX Pharmaceuticals, Inc.
WEX Pharmaceuticals, Inc. Medical DistributorsDistribution Services WEX Pharmaceuticals, Inc. develops, manufactures, and sells pharmaceutical products for pain management. The pain management solutions are provided through its proprietary platform technology based on TTX (Tetrodotoxin). It owns and operates its research, development and manufacturing facilities in China through its subsidiaries. The company was founded on June 3, 1987 and is headquartered in Vancouver, Canada. | Distribution Services |